Aqsens Health Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $418K
Latest Deal Amount
  • Investors
  • 4

Aqsens Health General Information

Description

Provider of a technology platform intended to be used for developing novel applications for qualitative and quantitative liquid analyses. The company's technology platform is used for monitoring residual scale inhibitors on site, enabling clients to access decision-making and hence make field operations to run smoothly.

Contact Information

Website
www.aqsens.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Electronic Equipment and Instruments
Other Industries
Other Commercial Products
Primary Office
  • Töölönkatu 6C
  • 00100 Helsinki
  • Finland
+358 040 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aqsens Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 24-Jan-2020 $418K 00000 00.000 Completed Generating Revenue
2. Later Stage VC 28-Mar-2017 000.00 000.00 000.00 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Aqsens Health’s complete valuation and funding history, request access »

Aqsens Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.00 00.00 00 00.00 0.000
Ordinary 00,000 00.00 00.00 00 00.00 0.000
Ordinary 35,778 $6.23 $6.23 1x $6.23 2.18%
Ordinary 230,000 $0.28 $0.28 1x $0.28 14.05%
To view Aqsens Health’s complete cap table history, request access »

Aqsens Health Executive Team (8)

Name Title Board Seat Contact Info
Timo Teimonen Chief Executive Officer & Board Member
Riikka Erkkilä Chief Operating Officer & Board Member
Jörkki Hyvönen Chief Technology Officer
Janne Kulpakko Chief Scientific Officer
Pekka Hänninen Co-Founder & Board Member
You’re viewing 5 of 8 executive team members. Get the full list »

Aqsens Health Board Members (9)

Name Representing Role Since
Alberto Haddad Aqsens Health Chairman of the Board 000 0000
Benjamin Michelin Aqsens Health Board Member 000 0000
Erkka Westerlund Aqsens Health Board Member 000 0000
Hele-Annele Aminoff Aqsens Health Board Member 000 0000
Niklas Törnkvist Newentures Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Aqsens Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aqsens Health Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tyson & Blake Growth/Expansion Minority 000 0000 000000 0
Keksintösäätiö Not-For-Profit Venture Capital Minority 000 0000 000000 0
Newentures Venture Capital Minority 000 0000 000000 0
Tekes Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Aqsens Health’s complete investors history, request access »